Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fletcher

Showing results (591-600 of 601) with videos related to

Pageof 61
Sort By:
Gut|May 2, 2024
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanismArmando Andres Roca Suarez, Marie-Laure Plissonnier, Xavier Grand, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2022
Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus InfectionDara Burdette, Anastasia Hyrina, Zhijuan Song, et al.
Mabs|September 24, 2025
A highly selective TCR-mimic antibody reveals unexpected mechanisms of HBV peptide-MHC recognition and previously unknown target biologyShahzada Khan, Jeremy Lum, Heather Stephenson, et al.
Cell Reports|July 27, 2025
Identification and engineering of potent bispecific antibodies that protect against herpes simplex virus recurrent diseaseChingwei V Lee, Hector Viadiu, Apurva Kalamkar, et al.
Antiviral Therapy|February 4, 2012
Potent immune activation in chronic hepatitis C patients upon administration of an oral inducer of endogenous interferons that acts via Toll-like receptor 7Andre Boonstra, Bi-Sheng Liu, Zwier M A Groothuismink, et al.
Gut|January 30, 2023
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitroMarzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al.
Journal of Hepatology|January 26, 2023
Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanismsJulie Lucifora, Dulce Alfaiate, Caroline Pons, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2024
Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infectionHarry L Janssen, Young-Suk Lim, Hyung Joon Kim, et al.
Gut|July 20, 2024
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis BAndrea Vecchi, Marzia Rossi, Camilla Tiezzi, et al.
Nature Communications|July 11, 2025
Oral dosing of the nucleoside analog obeldesivir is efficacious against RSV infection in African green monkeysJared Pitts, J Lizbeth Reyes Zamora, Savrina Manhas, et al.
Pageof 61

Showing results (591-600 of 601) with videos related to

Sort By:
Pageof 61
Gut|May 2, 2024
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanismArmando Andres Roca Suarez, Marie-Laure Plissonnier, Xavier Grand, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2022
Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus InfectionDara Burdette, Anastasia Hyrina, Zhijuan Song, et al.
Mabs|September 24, 2025
A highly selective TCR-mimic antibody reveals unexpected mechanisms of HBV peptide-MHC recognition and previously unknown target biologyShahzada Khan, Jeremy Lum, Heather Stephenson, et al.
Cell Reports|July 27, 2025
Identification and engineering of potent bispecific antibodies that protect against herpes simplex virus recurrent diseaseChingwei V Lee, Hector Viadiu, Apurva Kalamkar, et al.
Antiviral Therapy|February 4, 2012
Potent immune activation in chronic hepatitis C patients upon administration of an oral inducer of endogenous interferons that acts via Toll-like receptor 7Andre Boonstra, Bi-Sheng Liu, Zwier M A Groothuismink, et al.
Gut|January 30, 2023
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitroMarzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al.
Journal of Hepatology|January 26, 2023
Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanismsJulie Lucifora, Dulce Alfaiate, Caroline Pons, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2024
Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infectionHarry L Janssen, Young-Suk Lim, Hyung Joon Kim, et al.
Gut|July 20, 2024
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis BAndrea Vecchi, Marzia Rossi, Camilla Tiezzi, et al.
Nature Communications|July 11, 2025
Oral dosing of the nucleoside analog obeldesivir is efficacious against RSV infection in African green monkeysJared Pitts, J Lizbeth Reyes Zamora, Savrina Manhas, et al.
Pageof 61